Framework for a biopharmaceutical value chain

• US 20050165557A1
• Filed: 01/25/2005
• Published: 07/28/2005
• Est. Priority Date: 01/28/2004
• Status: Abandoned Application

• Current Assignee: Siemens Corp. (Siemens AG)
• Original Assignee: Siemens Corp. (Siemens AG)
• Inventors: Michelis, Rainer, Ladic, Lance Anthony, Rapaport, David
• Application Number:
  US11/043,392
• Publication Number:
  US 20050165557A1
• Time in Patent Office: Days
• US Class Current: 702/19
• CPC Class Codes: G06Q 30/02 Marketing; Price estimation or determination; Fundraising
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16H 40/67 for remote operation

Abstract

An information management framework includes a network of connected processors, an application data server connected to the network, and an infrastructure for interfacing with the application data server. The framework includes a first client accessing the application data server through the infrastructure and making drug candidate data available on the application data server via the network, and a second client for conducting drug candidate research via the network against the drug candidate data.

Claims

1. An information management framework comprising:

a network of connected processors;

an application data server connected to the network;

an infrastructure for interfacing with the application data server;

a first client accessing the application data server through the infrastructure and making drug candidate data available on the application data server via the network; and

a second client for conducting drug candidate research via the network against the drug candidate data.

2. The information management framework of claim 1, further comprising a hardware module providing hardware to the first client and/or the second client.

3. The information management framework of claim 1, further comprising a software module providing applications to the first client and/or the second client.

4. The information management framework of claim 3, wherein the software module comprises at least one of a data mining application, a simulation application, a modeling application, an imaging application, a decision support system, and a network security application.

5. The information management framework of claim 1, further comprising an advisory board module, wherein the advisory board module screens drug candidate data provided by the providing client for inclusion in the information management framework.

6. The information management framework of claim 1, wherein the infrastructure comprises a laboratory information management system.

7. The information management framework of claim 1, wherein the infrastructure comprises an e-commerce module for facilitating a transaction between the first client and the second client.

8. A method for promoting a drug candidate comprising:

providing drug candidate data to a library information management system;

creating an abstract of the drug candidate data;

providing an investor access to the abstract through the library information management system, the a library information management system coupled to a server hosting the abstract; and

facilitating a financial transaction between a provider of the drug candidate data and the investor.

9. The method of claim 8, further comprising assigning a value to the drug candidate data.

10. The method of claim 8, wherein the financial transaction includes a sale of the drug candidate data to the investor.

11. The method of claim 8, wherein the financial transaction includes a promise to pay a royalty to the provider of the drug candidate data by the investor in exchange for the drug candidate data.

12. The method of claim 8, further comprising aggregating the drug candidate data with data in the library information management system.

13. The method of claim 8, further comprising modifying the drug candidate data in compliance with privacy regulations.

14. The method of claim 8, further comprising encrypting the drug candidate data.

15. The method of claim 14, wherein the financial transaction includes providing the investor with a key for decrypting the drug candidate data.

16. An infrastructure for promoting a drug candidate comprising:

a communications network coupled to a plurality of clients;

a server providing an abstract of drug candidate data via the communications network;

a library information management system for processing the abstract of the drug candidate data; and

a commerce module for purchasing drug candidate data from the provider.

17. The infrastructure of claim 16, wherein the library information management system enables at least one of grouping abstracts, tracking abstract updates, and viewing abstracts.

18. The infrastructure of claim 16, wherein the library information management system enables at least one of grouping purchased drug candidate data, tracking purchased drug candidate data updates, and viewing purchased drug candidate data.